Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $110.8800 (3.54%) ($105.9200 - $111.4600) on Fri. Apr. 1, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.82% (three month average) | RSI | 66 | Latest Price | $110.8800(3.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.6% a day on average for past five trading days. | Weekly Trend | LGND advances 3.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(56%) XBI(56%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.41% in a week (0% probabilities). VIXM(-16%) TLT(-15%) UUP(-8%) GDXJ(-5%) IPO(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.41% (StdDev 2.82%) | Hourly BBV | 0 () | Intraday Trend | 4.3% | | | |
|
5 Day Moving Average | $106.06(4.54%) | 10 Day Moving Average | $103.95(6.67%) | 20 Day Moving Average | $101.7(9.03%) | To recent high | 0% | To recent low | 29.2% | Market Cap | $1.782b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |